Infection  >>  Green Cross TD Vaccine (GC1107)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Green Cross TD Vaccine (GC1107) / GC Biopharma
NCT01402713: To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children

Completed
2/3
311
RoW
GC1107, TD_PUR INJ / SK Td vaccine
Green Cross Corporation
Bacterial Infections
11/13
11/13

Download Options